Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,500
Closed -$250K 221
2023
Q4
$250K Hold
3,500
0.09% 180
2023
Q3
$243K Hold
3,500
0.12% 146
2023
Q2
$283K Sell
3,500
-1,500
-30% -$123K 0.12% 141
2023
Q1
$404K Hold
5,000
0.21% 113
2022
Q4
$374K Hold
5,000
0.21% 111
2022
Q3
$323K Sell
5,000
-2,500
-33% -$173K 0.2% 111
2022
Q2
$520K Hold
7,500
0.31% 75
2022
Q1
$576K Sell
7,500
-30
-0.4% -$2.16K 0.27% 75
2021
Q4
$576K Buy
+7,530
New +$554K 0.24% 89

Other funds holding HOLX

Wealth Effects's HOLX Position: Q1 2024 in Review

Wealth Effects sold out of Hologic (HOLX) in Q1 2024, closing a stake of 3,500 shares — an estimated $250K sold.

Wealth Effects first reported a position in HOLX in Q4 2021 and held it in 9 quarters. The position peaked at $576K in Q1 2022. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Wealth Effects reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Wealth Effects sold 3,500 Hologic shares in Q1 2024, an estimated $250K.
  • Wealth Effects first reported a position in Hologic in Q4 2021 and held it in 9 quarters.
  • Wealth Effects's Hologic position peaked at $576K in Q1 2022.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Wealth Effects's 13F filing for Q1 2024, filed 22 Apr 2024.